These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25872609)

  • 1. The impact of epidemics of vaccine-preventable disease on vaccine uptake: lessons from the 2011-2012 US pertussis epidemic.
    Wolf ER; Rowhani-Rahbar A; Opel DJ
    Expert Rev Vaccines; 2015 Jul; 14(7):923-33. PubMed ID: 25872609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis vaccine performance in an epidemic year-Oregon, 2012.
    Liko J; Robison SG; Cieslak PR
    Clin Infect Dis; 2014 Jul; 59(2):261-3. PubMed ID: 24748523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a pertussis epidemic on infant vaccination in Washington state.
    Wolf ER; Opel D; DeHart MP; Warren J; Rowhani-Rahbar A
    Pediatrics; 2014 Sep; 134(3):456-64. PubMed ID: 25136046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella pertussis: why is it still circulating?
    Guiso N
    J Infect; 2014 Jan; 68 Suppl 1():S119-24. PubMed ID: 24103807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.
    Sheridan SL; Frith K; Snelling TL; Grimwood K; McIntyre PB; Lambert SB
    Expert Rev Vaccines; 2014 Sep; 13(9):1081-106. PubMed ID: 25093268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis epidemic--Washington, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jul; 61(28):517-22. PubMed ID: 22810264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-emergence of pertussis: what are the solutions?
    Libster R; Edwards KM
    Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health Council of the Netherlands advisory report 'Vaccination against pertussis'--time for a new vaccine].
    Visser HK
    Ned Tijdschr Geneeskd; 2004 May; 148(19):916-8. PubMed ID: 15160555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do pertussis vaccines fail?
    Cherry JD
    Pediatrics; 2012 May; 129(5):968-70. PubMed ID: 22529282
    [No Abstract]   [Full Text] [Related]  

  • 11. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
    Matter HC; Schmidt-Schläpfer G; Zimmermann H
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Global pertussis epidemiology and immunization strategies].
    Zhang WH
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):467-72. PubMed ID: 20084979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australian vaccine preventable disease epidemiological review series: pertussis, 2006-2012.
    Pillsbury A; Quinn HE; McIntyre PB
    Commun Dis Intell Q Rep; 2014 Sep; 38(3):E179-94. PubMed ID: 25391404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pertussis epidemics and changes in the immunization schedules: Chile, 2012: unanswered questions?].
    Cabello FC
    Rev Chilena Infectol; 2012 Dec; 29(6):692-3; author reply 694-5. PubMed ID: 23412048
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on vaccination against pertussis.
    Weber CJ
    Urol Nurs; 2007 Apr; 27(2):155-6. PubMed ID: 17494458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.
    Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B
    Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whooping cough—where are we now? A review.
    Kiedrzynski T; Bissielo A; Suryaprakash M; Bandaranayake D
    N Z Med J; 2015 Jun; 128(1416):21-7. PubMed ID: 26117672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modeling of delayed pertussis vaccination in infants.
    Pesco P; Bergero P; Fabricius G; Hozbor D
    Vaccine; 2015 Oct; 33(41):5475-5480. PubMed ID: 26187255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.